Candriam SCA’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-509,000	Closed	-$3.38M	–	818
2018 Q4	$3.38M	Hold	509,000	–	–	0.05%	356
2018 Q3	$5.43M	Buy	509,000 +137,000	+37%	+$1.57M	0.07%	297
2018 Q2	$4.46M	Buy	372,000 +104,000	+39%	+$1.06M	0.07%	317
2018 Q1	$2.3M	Hold	268,000	–	–	0.04%	450
2017 Q4	$2.65M	Sell	268,000 -25,000	-9%	-$260K	0.05%	400
2017 Q3	$3.6M	Hold	293,000	–	–	0.06%	336
2017 Q2	$4.82M	Buy	293,000 +33,000	+13%	+$511K	0.09%	269
2017 Q1	$3.73M	Buy	260,000 +65,000	+33%	+$964K	0.07%	316
2016 Q4	$2.7M	Hold	195,000	–	–	0.06%	312
2016 Q3	$3.52M	Buy	195,000 +67,000	+52%	+$1.08M	0.08%	255
2016 Q2	$1.84M	Sell	128,000 -25,000	-16%	-$339K	0.05%	327
2016 Q1	$1.82M	Sell	153,000 -12,000	-7%	-$126K	0.05%	336
2015 Q4	$2.2M	Buy	+165,000	New	+$2.03M	0.06%	283
2015 Q2	–	Sell	-81,429	Closed	-$538K	–	653
2015 Q1	$538K	Hold	81,429	–	–	0.01%	535
2014 Q4	$519K	Buy	+81,429	New	+$656K	0.01%	517